These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 63929)

  • 1. Phytohemagglutin-induced lymphocyte transformation in oral contraceptive users.
    Keller AJ; Irvine WJ; Jordan J; Loudon NB
    Obstet Gynecol; 1977 Jan; 49(1):83-91. PubMed ID: 63929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of hyperprolactinemia during oral contraceptive therapy.
    Reyniak JV; Wenof M; Aubert JM; Stangel JJ
    Obstet Gynecol; 1980 Jan; 55(1):8-11. PubMed ID: 7352067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins.
    Bradley DD; Wingerd J; Petitti DB; Krauss RM; Ramcharan S
    N Engl J Med; 1978 Jul; 299(1):17-20. PubMed ID: 207983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative enhancement of dinitrochlorobenzene responsivity in women receiving oral contraceptives.
    Rea TH
    Arch Dermatol; 1979 Mar; 115(3):361-2. PubMed ID: 434857
    [No Abstract]   [Full Text] [Related]  

  • 5. Depressed PHA--induced lymphocyte transformation in women taking oral contraceptives.
    Niedbała W; Nowak J
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):867-70. PubMed ID: 7349108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune studies in oral contraceptive users.
    Ramalakshmi BA; Jagadeesan V; Prema K
    Contraception; 1979 Oct; 20(4):417-25. PubMed ID: 315858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological status of women with prolonged oral contraceptives and occurrence of giardiasis.
    Mazumder DN; Ghose N; Mitra J; Dutta G; Santra A
    J Indian Med Assoc; 1990 May; 88(5):129-31. PubMed ID: 2280071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum gamma-glutamyl transpeptidase activity in viral hepatitis: suppression in pregnancy and by birth control pills.
    Combes B; Shore GM; Cunningham FG; Walker FB; Shorey JW; Ware A
    Gastroenterology; 1977 Feb; 72(2):271-4. PubMed ID: 12064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen containing oral contraceptives and antithrombin III activity.
    Rákóczi I; Nagy I; Szigetvári I; Losonczy H; Hadnagy J; Gáti I
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):281-6. PubMed ID: 4471272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body weight change during use of a monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene with a comparison of the women who completed versus those who prematurely discontinued intake.
    Endrikat J; Gerlinger C; Cronin M; Wessel J; Ruebig A; Rosenbaum P; Düsterberg B
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):199-204. PubMed ID: 11848649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of estrogen on the blast transformation of lymphocytes and interleukin-2 production in lupus erythematosus].
    Pozsonyi T; Jakab L; Jakab L; Onody K; Cseh K; Kalabay L
    Orv Hetil; 1992 May; 133(19):1167-71. PubMed ID: 1584598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A; Bonnar J
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptive estrogen and plasma lipid levels.
    Hedlin A; Kuksis A; Geher K
    Obstet Gynecol; 1978 Oct; 52(4):430-5. PubMed ID: 714324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oral contraceptives on vitamin B12 metabolism.
    Shojania AM; Wylie B
    Am J Obstet Gynecol; 1979 Sep; 135(1):129-34. PubMed ID: 474643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative studies into effects of synthetic oestrogens and gestagens on certain serum protein fractions under standardised conditions (author's transl)].
    Klinger G; Stelzner A; Krause G; Tarnick M; Scheler R; Schubert H; Börner A; Carol W
    Zentralbl Gynakol; 1980; 102(24):1410-20. PubMed ID: 6164183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
    Briggs MH
    J Reprod Med; 1983 Jan; 28(1 Suppl):92-9. PubMed ID: 6403706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on cell-mediated immunity in women using different fertility regulating methods.
    Tezabwala BU; Hegde UC; Joshi JV; Jaswaney VL; Rao SS
    J Clin Lab Immunol; 1983 Apr; 10(4):199-202. PubMed ID: 6864765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte transformation in newborns, women and those who had used oral contraceptives.
    Bishun NP; Williams DC; Raven RW; Mills J
    Cytobios; 1976; 16(63-64):193-202. PubMed ID: 1027549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell mediated immunity in healthy women taking oral contraceptives.
    Dwyer JM; Knox GE; Mangi RJ
    Yale J Biol Med; 1975 May; 48(2):91-5. PubMed ID: 1098291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.